Skip to main content
OpenTrials
Completed

NCT Number: NCT05492240

Advancing Rehabilitation Paradigms for Older Adults in Skilled Nursing Facilities

This cluster randomized clinical trial seeks to provide large-scale, foundational evidence that high-intensity rehabilitation is effective and can be systematically implemented to improve functional outcomes for patients admitted to skilled nursing facilities following hospitalization. Additionally, this study will generate a descriptive overview of factors that predict implementation success while informing effective implementation strategies for future skilled nursing facilities innovation.

Completed

Looking for future studies?

Notify Me

Key information

Age range

50 year–120 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

University of Colorado Denver, Anschutz Medical Campus, Aurora, Colorado, United States

Loading trial locations.

About this study

In the U.S., 8.37 million adults over 65 will experience a hospital stay over the next year, which often has serious and long-lasting consequences including profound deterioration in physical function. Following a hospital stay, around 1.35 million patients with deconditioning require rehabilitation in a skilled nursing facility (SNF) each year to address the deleterious musculoskeletal and functional deficits from deconditioning. More than 64% of patients discharge from SNFs at functional levels that predispose them to adverse events, including rehospitalization, failing health, disability, institutionalization, or death. Physical function is a known modifiable predictor of these deleterious events, which can be addressed with rehabilitation. Therefore, more progressive and targeted musculoskeletal rehabilitation strategies that optimize physical function more effectively are needed.

Therefore, the purpose of this study is to determine the effectiveness of a high-intensity rehabilitation approach (also referred to as i-STRONGER) at multiple skilled nursing facilities (SNFs), while evaluating characteristics of successful implementation through a rigorous, pragmatic cluster randomized controlled trial (16 Intervention SNFs vs 16 Usual Care SNFs). The investigators will promote high-intensity rehabilitation delivery to patients in an effort to address poor physical function outcomes. Specifically, the investigators will train rehabilitation clinicians at Intervention sites using distance-based instruction and collect study outcomes via the electronic medical record. Additionally, the investigators will gather quantitative and qualitative data (mixed methods) to evaluate processes, clinician-specific characteristics, and facility-specific contexts of implementation. The study methods seek to maximize successful reach, effectiveness, adoption, implementation, and maintenance (RE-AIM) across Intervention sites. The implementation strategy is informed by the RE-AIM framework and integrated with educational and behavioral theories to facilitate clinical adoption of high-intensity rehabilitation.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Rehabilitation staff at enrolled sites will participate in research activities, as indicated by group assignment.

Site Inclusion Criteria:

  • Aegis Therapies-contracted skilled nursing facility (SNF)
  • Admits approximately 15 patients per month for short term rehabilitation

Patient Inclusion Criteria:

  • At least 50 years of age
  • Admitted to a SNF from the hospital
  • Ambulatory upon SNF admission

Patient Exclusion Criteria:

  • Contraindications to high-intensity resistance training, per American College of Sports Medicine Exercise Testing and Prescription
  • Lower extremity weight-bearing precautions
  • Neurological diagnosis (e.g., Cerebral vascular accident, Multiple Sclerosis, Parkinson's disease)
  • Subsequent SNF admission

Treatment and study plan

i-STRONGER

Other

An 8RM is the dose necessary for most effective strength gains in community-dwelling older adults, and is equivalent to 80% of a one repetition max, which is the maximal load needed to voluntarily complete one repetition of a given exercise with proper form. Clinicians will tailor the intervention for each activity, so the patient achieves 8 repetitions with failure on the 9th repetition. Failure is the inability to complete a repetition through the full, available range of motion without significant compensation. Further, high-intensity dosing requires continuous, volitional effort from the patient; therefore, incorporation of motivational interviewing strategies across sessions will maximize patient effort and self-efficacy.

Usual Care

Other

Usual Care SNFs will continue with routine collection and documentation of physical performance outcomes (gait speed, SPPB, Modified Barthel ADL Index) as standard practice. Furthermore, a combination of chart reviews and on-site or remote observation will allow for characterization of usual care components for descriptive comparison. Importantly, the Usual Care SNF including the facility, rehabilitation clinicians, and patients will not have access to i-STRONGER materials.

Primary outcomes

  1. Change in Gait Speed

    Time frame: From date of admission into the SNF to date of discharge from the SNF, which would be an approximate average of 21 days

    Gait speed will be measured in meters/second using the time it takes to walk a 4-meter path at usual speed using a stopwatch.

Secondary outcomes

  1. Change in Short Physical Performance Battery (SPPB)

    Time frame: From date of admission into the SNF to date of discharge from the SNF, which would be an approximate average of 21 days

    The SPPB is comprised of 3 tasks: a hierarchical standing balance test (side-by-side, semi-tandem, and tandem), a 4-meter usual gait speed, and a 5-time sit-to-stand from a standardized chair. Each subtask is scored (based on time) from 0-4 points and then summarized into a total score of 0-12 points, where 12 points represents the highest performance.

  2. Post-discharge Rehospitalization Rate

    Time frame: From date of discharge from the SNF, assessed up to 30 days

    The proportion of patients eligible for high-intensity rehabilitation who return to the hospital within 30 days of discharge from the SNF.

Other outcomes

  1. Change in Total Score Modified Barthel ADL Index (MBI)

    Time frame: From date of admission into the SNF to date of discharge from the SNF, which would be an approximate average of 21 days

    The Modified Barthel ADL Index assesses the ability to perform basic Activities of Daily Living (ADL) tasks. Total score range is 0-100. Total score is commuted by summing dependence across 10 ADL tasks: chair/bed transfers, ambulation, stair climbing, toilet transfers, bowel control, bladder control, bathing, dressing, personal hygiene (grooming), and feeding. Higher scores indicate increased independence.

  2. RE-AIM Component: Reach

    Time frame: Up to 16 months

    Proportion of patients treated with high-intensity rehabilitation out of all eligible patients.

  3. RE-AIM Component: Adoption

    Time frame: Up to 16 months

    Proportion of clinicians using high-intensity rehabilitation with at least 75% of eligible patients out of all trained clinicians at Intervention sites.

  4. RE-AIM Component: Implementation

    Time frame: Up to 16 months

    Proportion of completed high-intensity rehabilitation elements out of all intervention elements assessed by a fidelity checklist.

  5. RE-AIM Component: Maintenance

    Time frame: Assessed from 16 months up to 22 months

    Proportion of facilities that sufficiently completed high-intensity elements out of all intervention elements assessed by a fidelity checklist.

Sponsors and collaborators

Lead sponsor

University of Colorado, Denver

Other

Collaborators

  • Aegis Therapies, Inc.
  • National Institute on Aging (NIA)

Registry information

Important dates

Study start
2022
Primary completion
2025
Study completion
2025
First posted
Aug 8, 2022
Registry last updated
Jan 7, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.